Mohammed Rassool to Biological Availability
This is a "connection" page, showing publications Mohammed Rassool has written about Biological Availability.
Connection Strength
0,036
-
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial. Lancet HIV. 2017 11; 4(11):e486-e494.
Score: 0,036